Related by context. All words. (Click for frequent words.) 68 Chronic Heart Failure 68 recurrent glioblastoma multiforme 68 biliary tract cancer 67 advanced hepatocellular carcinoma 67 metastatic malignant 67 NMIBC 67 antiarrhythmic drug 67 Acute Decompensated Heart Failure 67 invasive candidiasis 67 Coronary Artery Bypass Graft 67 unstable angina UA 67 Renal Cell Carcinoma RCC 67 relapsed MM 66 Venous thromboembolism 66 Adjunctive 66 Acute Coronary Syndrome 66 Prospective Randomized 66 HeFH 66 Investigational Treatment 66 relapsing multiple sclerosis 66 invasive aspergillosis 66 patientswith 66 stage IIIB 66 de novo kidney transplant 66 Unstable Angina 66 VFEND 66 Decompensated Heart Failure 66 Patients Treated With 66 Degarelix 66 polycythemia vera essential thrombocythemia 66 Tolvaptan 66 primary hyperparathyroidism 66 NSTEMI 66 acute coronary syndrome 66 visilizumab 65 ACTEMRA TM 65 ATACAND 65 Thrombolysis 65 Myelodysplastic Syndrome MDS 65 vWD 65 dual endothelin receptor antagonist 65 AGILECT R 65 Hormone Refractory Prostate Cancer 65 antithrombotic therapy 65 chemoradiation therapy 65 NYHA Class II 65 Soft Tissue Sarcoma 65 solid organ transplantation 65 neoadjuvant treatment 65 cinacalcet 65 Rheumatoid Arthritis RA 65 recurrent DVT 65 Surgical resection 65 Afib 65 gefitinib Iressa 65 Systemic Lupus Erythematosus SLE 65 CIMZIA TM certolizumab pegol 65 ARCOXIA 65 CYT# potent vascular disrupting 65 GW# [003] 65 Chronic Renal Failure 65 toenail onychomycosis 65 Ischemic 65 benign prostatic hypertrophy BPH 65 Acute Coronary Syndromes 65 Neovascular AMD 64 non valvular atrial 64 immunomodulatory therapy 64 Pemetrexed 64 Liver transplantation 64 abacavir Ziagen 64 chronic myocardial ischemia 64 oral anticoagulation 64 Heterozygous Familial Hypercholesterolemia 64 nonmetastatic 64 metastatic gastric 64 somatostatin analog 64 ribavirin RBV 64 Relapsed Refractory 64 micafungin 64 Aflibercept 64 interferon ribavirin 64 Acute Ischemic Stroke 64 acute coronary syndromes ACS 64 overactive bladder syndrome 64 secondary hyperparathyroidism 64 smoldering myeloma 64 symptomatic intracranial 64 antithrombotics 64 decompensated heart failure 64 Major Depressive Disorder MDD 64 PEGINTRON TM 64 TMP SMX 64 AA Amyloidosis 64 Pegylated Liposomal Doxorubicin 64 eosinophilic asthma 64 paclitaxel poliglumex 64 hepatorenal syndrome 64 completely resected 64 thetreatment 64 ST Elevation Myocardial 64 diabetic gastroparesis 64 nicardipine 64 Gastrointestinal Stromal Tumors 64 sunitinib malate 64 beta blocker therapy 64 catheter occlusion 64 Bosutinib 64 fosbretabulin 64 BENICAR HCT 64 non splenectomized 64 immune thrombocytopenic purpura ITP 64 miconazole Lauriad ® 64 Nesiritide 64 Hepatocellular Carcinoma HCC 64 Systemic Sclerosis 64 Ranibizumab 64 Diabetic Macular Edema 64 Myelodysplastic Syndrome 64 recurrent metastatic 64 failure ADHF 64 idiopathic thrombocytopenic purpura ITP 64 receptor tyrosine kinase inhibitor 64 Endarterectomy 64 venous thromboembolic disease 64 bendamustine 64 pancreatic insufficiency 64 PEG IFN 64 oxaliplatin Eloxatin 64 Cardiotoxicity 64 idiopathic Parkinson disease 64 Advanced Melanoma 64 Hypotension 64 NSTE ACS 64 Adjuvant Treatment 64 postoperative atrial fibrillation 64 superficial bladder cancer 64 terlipressin 64 Renal Artery 64 constipation OIC 64 Pivotal Trial 64 Overactive Bladder 63 aspirin clopidogrel 63 pediatric Crohn disease 63 Angioedema 63 primary percutaneous coronary 63 Pharmacokinetics PK 63 unresectable tumors 63 diabetes mellitus DM 63 artery stenosis 63 colorectal adenoma 63 kidney urologic 63 NATRECOR R 63 tirofiban 63 mycosis fungoides 63 Chronic Sinusitis 63 GP IIb IIIa inhibitors 63 clevidipine 63 Generalised Anxiety Disorder 63 unfractionated heparin UFH 63 INVEGA ® 63 sorafenib Nexavar 63 topically administered 63 STRIDE PD 63 pain palliation 63 chemoradiotherapy 63 complement inhibitor eculizumab 63 UA NSTEMI 63 coronary intervention 63 Diabetic Foot Ulcer 63 NATRECOR ® 63 Ventricular Tachycardia 63 postoperative AF 63 Diabetic Macular Edema DME 63 icatibant 63 essential thrombocythemia ET 63 Inhalation Solution 63 Microwave Ablation System 63 IBS C 63 Fingolimod 63 Lamotrigine 63 histologically confirmed 63 PAOD 63 colorectal liver metastases 63 Critical Limb Ischemia CLI 63 DAPT 63 Renal Impairment 63 unresectable stage 63 hyperphenylalaninemia HPA due 63 4mg/kg 63 clinically evaluable 63 opioid induced constipation OIC 63 CRVO 63 pharmacokinetic PK study 63 comparator arm 63 salmeterol fluticasone 63 GH deficiency 63 acute coronary syndromes 63 Severe Primary IGFD 63 Helicobacter pylori eradication 63 Peripheral Arterial 63 polyarticular 63 Ischemic Stroke 63 Patients Receiving 63 heparin induced thrombocytopenia 63 Papillary 63 mild renal insufficiency 63 biologic DMARD 63 recurrent glioblastoma 63 juvenile idiopathic arthritis 63 alpha 2a 63 metastatic GIST 63 Adjunctive Therapy 63 systemic fungal infections 63 Liprotamase 63 vapreotide acetate 63 AEGR 63 platelet inhibitor 63 PICSO ® 63 pamidronate 63 acute decompensated heart 63 Abciximab 63 RAPAFLO R 63 Doxil ® 63 pancreatic adenocarcinoma 63 adalimumab Humira 63 FluCAM arm 63 antiretroviral naïve 63 Natalizumab 63 Fondaparinux 63 relapsing remitting MS RRMS 63 Hypertriglyceridemia 63 underwent resection 63 induce orthostatic hypotension 63 antibody MAb 63 Ziprasidone 63 Severe Sepsis 63 intra abdominal abscess 63 Improves Outcomes 63 extracranial 63 SHPT 63 Temodar ® 63 alfuzosin 63 Idiopathic Pulmonary Fibrosis 63 Naive Patients 63 Asthma COPD 63 thromboprophylaxis 63 chronic HCV 63 HBeAg negative 63 milrinone 63 CLINICAL PHARMACOLOGY 63 Benign Prostatic Hyperplasia BPH 63 Complicated Skin 63 SPRYCEL ® 63 idiopathic thrombocytopenic purpura 63 Bivalirudin 63 relapsed CLL 63 Nebulized 63 mixed hyperlipidemia 63 metastatic RCC 63 Mitomycin C 63 NeuroStar TMS Therapy 63 TMS Therapy 63 Nilotinib 63 Antiviral Therapy 63 metastatic neuroendocrine tumors 63 CHAMPION PCI 63 Anticoagulation 63 infarction NSTEMI 63 cathepsin K inhibitor 62 variceal bleeding 62 Pegylated Interferon 62 adult chronic ITP 62 Phase 2b Clinical Trial 62 Heart Transplant Recipients 62 unstable angina pectoris 62 efalizumab 62 functional mitral regurgitation 62 Platinol ® 62 Fibrin Pad 62 reteplase 62 Dacogen injection 62 VTE prophylaxis 62 rheumatoid arthritis osteoarthritis ankylosing 62 Lenalidomide 62 delivers fluocinolone acetonide FA 62 PEGylated interferon beta 1a 62 nonalcoholic steatohepatitis 62 atypical Hemolytic Uremic Syndrome 62 certolizumab 62 overt nephropathy 62 heFH 62 treatment naive genotype 62 LEUKINE 62 hoFH 62 adjuvant radiotherapy 62 Vernakalant 62 prospectively enrolled 62 myelodysplastic myeloproliferative diseases 62 CLL SLL 62 TYGACIL 62 ADP receptor antagonist 62 Cimzia TM 62 nimodipine 62 moderate renal impairment 62 BCR ABL inhibitor 62 de novo AML 62 divalproex sodium 62 dasatinib Sprycel 62 unfavorable cytogenetics 62 ALGRX 62 sustained ventricular tachycardia 62 Metastatic Prostate Cancer 62 venous stasis ulcers 62 leiomyomas 62 paroxysmal AF 62 Benign Prostatic Hyperplasia 62 ALA PDT 62 phase IIb clinical 62 paroxysmal atrial fibrillation 62 Hematologic 62 direct thrombin inhibitors 62 acetonide FA 62 pulmonary hypertension PH 62 chronic periodontitis 62 morphometric vertebral fractures 62 ST Segment Elevation 62 Oral Fingolimod 62 Plaquenil 62 atherothrombotic events 62 Navelbine ® 62 Percutaneous Tibial Nerve Stimulation 62 thalidomide Thalomid 62 reduce serum phosphate 62 T2DM 62 hematopoietic cancers 62 5-FU/LV 62 Phase IIb Clinical Trial 62 MIRAPEX ER 62 Fibromyalgia Syndrome 62 EFFEXOR XR 62 See CLINICAL PHARMACOLOGY 62 etanercept Enbrel 62 Gastrointestinal GI 62 Ozarelix 62 Moxifloxacin 62 intravesical therapy 62 hepatic metastases 62 myocardial infarction ventricular fibrillation 62 Motesanib 62 herpetic keratitis 62 Relapsing remitting MS 62 metastatic pancreatic 62 ACE Inhibitors 62 BENICAR 62 Acute MI 62 Pyridorin 62 herpes labialis 62 Hydroxyurea 62 Recurrent Glioblastoma 62 ABVD 62 rheumatoid arthritis psoriatic arthritis 62 rFVIIa 62 Bronchiectasis 62 drotrecogin alfa activated 62 pegylated interferon alfa 2b 62 Kepivance 62 Estrogen Receptor 62 von Willebrand disease 62 Occlusive Disease 62 candidemia 62 Acute Myocardial Infarction 62 APPRAISE 62 proliferative retinopathy 62 stage IIIb IV 62 Omacetaxine 62 Tarceva TM 62 Generalized Anxiety Disorder 62 aflibercept VEGF Trap 62 smoldering multiple myeloma 62 rituximab Rituxan 62 Intravenous immunoglobulin 62 Xelox 62 esophageal candidiasis 62 Atypical Hemolytic Uremic Syndrome 62 CTAP# 62 oral rivaroxaban 62 Relapsing Remitting Multiple Sclerosis 62 cisplatin gemcitabine 62 deep venous thromboses 62 thrombocytopenic 62 Cutaneous T 62 dyslipidemia hypertension diabetes 62 sJIA 62 vinorelbine tartrate 62 ARIXTRA 62 pegaptanib 62 NAVISTAR R 62 infusional 62 retinal vein occlusion 62 chronic thromboembolic pulmonary 62 β blockers 62 papillary renal cell carcinoma 62 Intravitreal 62 Chronic Pelvic Pain 62 patients undergoing CABG 62 Phase Ib Clinical Trial 62 MELAS 62 retinal vein occlusion induced 62 IL# PE#QQR 62 beta 1a 62 Chronic Prostatitis 62 blinded randomized placebo controlled 62 Val HeFT 62 glatiramer acetate 62 haematologic 62 Folfox 62 oral antidiabetic medication 62 phase IIb trial 62 recurrent malignant glioma 62 Neoadjuvant 62 Postmenopausal hormone therapy 62 FDA Approvals 62 intracerebral hemorrhage ICH 62 fallopian tube carcinoma 62 Metastatic Pancreatic Cancer 62 Peginterferon 62 ara C 62 Teriflunomide 62 intermittent claudication 62 gastrointestinal stromal tumors GIST 62 Angiox R 62 Dual Antiplatelet Therapy 62 RE LY 62 coronary revascularization 62 bivalirudin alone 62 Pharmacologic 62 ADHF 62 Ceflatonin R 62 Orphan Status 62 tuberous sclerosis TS 62 thrombolytic therapy 62 erlotinib Tarceva ® 62 SinuNase TM 62 symptomatic VTE 62 colesevelam HCl 62 minimally symptomatic 62 Meets Primary Endpoint 62 Factor VIIa 62 atherosclerotic renal artery stenosis 62 liposomal amphotericin B 62 doxorubicin docetaxel 62 AVONEX ® 62 Chronic Myeloid Leukemia 62 MAGE A3 ASCI 62 Pivotal Phase III 62 PRADAXA 62 chronic eosinophilic leukemia 62 radiotherapy RT 62 alefacept 62 Dupuytren Disease 62 chronic immune thrombocytopenic 62 acadesine 62 Phase IIa Clinical Trial 62 chronic hemodialysis 62 Initiate Clinical Trial 62 tipranavir ritonavir 62 fibromyalgia syndrome 62 phase IIb study 61 AVASTIN 61 Bayer Onyx 61 Aneurysm Repair 61 allogeneic hematopoietic stem cell 61 Allergic Rhinitis 61 acute GvHD 61 BCG refractory 61 J Am Coll 61 recurrent GBM 61 Major Depressive Disorder 61 IGFD 61 symptomatic hyponatremia 61 basal cell carcinoma BCC 61 preoperative chemotherapy 61 Temsirolimus 61 Adjuvant chemotherapy 61 FOLFOX6 61 8mg/kg 61 Fabry Disease 61 CIMZIA TM 61 inhaled tobramycin 61 erythematosus 61 systolic hypertension 61 severe oral mucositis 61 anthracyclines taxanes 61 Elitek 61 PLX STROKE targeting 61 Ophena TM 61 Uroxatral 61 glucocorticoid induced osteoporosis 61 diarrhea predominant irritable 61 Chronic HCV 61 rhIGF-I/rhIGFBP-3 61 ZOLINZA 61 Interferon beta 61 Glatiramer Acetate 61 argatroban 61 ORENCIA ® 61 IV NSCLC 61 nonischemic 61 reslizumab 61 Diabetic nephropathy 61 urothelial carcinoma 61 Refractory Angina 61 Exacerbation 61 novel oral anticoagulant 61 VAPRISOL 61 castrate resistant prostate cancer 61 psoriatic arthritis PsA 61 ISTODAX ® 61 hematological malignancy 61 Myocardial Infarction Study 61 developing Bicifadine serotonin 61 treat benign prostatic 61 antiangiogenic therapy 61 Chronic Lymphocytic Leukemia CLL 61 Ischemia 61 Myelofibrosis 61 fluticasone salmeterol 61 EXJADE 61 Abrupt discontinuation 61 Vinorelbine 61 regorafenib 61 RELOVAIR ™ 61 metastatic renal cell carcinoma 61 Familial Hypercholesterolemia 61 Known hypersensitivity 61 Hyperlipidemia 61 Valsartan 61 Cypher Stent 61 LHRH receptor positive 61 Exemestane 61 Plaque Psoriasis 61 Brinavess 61 dyslipidemia 61 Myelodysplastic syndromes MDS 61 dopamine partial agonist 61 cisplatin chemotherapy 61 symptomatic BPH 61 stable angina pectoris 61 epoetin alpha 61 esophagogastric 61 anticholinergic agents 61 Treated Patients 61 Phase IIb Trial 61 dalteparin 61 Prolongs Survival 61 leukemia AML 61 non metastatic osteosarcoma 61 refractory NSCLC 61 exocrine pancreatic insufficiency EPI 61 Treatment Resistant 61 rFSH 61 ximelagatran 61 INCB# [003] 61 arterial thrombosis 61 Aggrastat 61 Sapacitabine 61 briakinumab 61 familial amyloidotic polyneuropathy FAP 61 docetaxel Taxotere ® 61 calcineurin inhibitor 61 Alemtuzumab 61 galiximab 61 Bipolar Depression 61 olmesartan 61 DOXIL 61 Mg Usa 61 infliximab Remicade 61 ALVESCO ® 61 Velcade bortezomib 61 decitabine 61 FOLFOX4 61 Relapsing Multiple Sclerosis 61 BARACLUDE ® 61 atherothrombosis 61 Vidaza azacitidine 61 prospectively evaluated 61 Prophylactic Treatment 61 drug eluting stent implantation 61 CINQUIL 61 Mg Uk 61 Nonsurgical 61 hepatocellular cancer 61 psoriasis vulgaris 61 Clinical Efficacy 61 Juvenile Idiopathic Arthritis 61 Retisert TM 61 CYPHER Stent 61 cell lymphoma CTCL 61 LUMINATE 61 Initiates Clinical Trial 61 Cholesterol Levels SPARCL 61 erythematosus SLE 61 achieved CCyR 61 mcg BID 61 dasatinib Sprycel ® 61 T1c 61 EECP R 61 HSCT 61 ACTOS ® 61 G CSFs 61 Parenteral Nutrition 61 Randomized Evaluation 61 Multiple Ascending Dose 61 Clinical Outcome 61 leukotriene receptor antagonist 61 squamous histology 61 Castration Resistant Prostate Cancer 61 metastatic bladder 61 Ranolazine 61 mg p = 61 acute myocardial infarction AMI 61 primidone 61 Belldegrun 61 glatiramer 61 sargramostim 61 bisoprolol 61 immunosuppressive therapies 61 OHR/AVR# 61 beta blockers ACE inhibitors 61 Dupuytren Contracture 61 Carvedilol 61 sunitinib Sutent 61 undergoing elective percutaneous 61 cardiovascular calcification 61 Bare Metal Stent 61 patients undergoing percutaneous 61 Noxafil 61 NNT = 61 Betaferon R 61 glycoprotein IIb IIIa inhibitor 61 Cancidas 61 Comorbidities 61 #mg BID [001] 61 Renal Cell Carcinoma 61 Contraindications 61 Neovascular Age Related Macular 61 Tyrosine Kinase Inhibitors 61 Hepatocellular Carcinoma 61 ocular inflammatory 61 aripiprazole Abilify 61 antiplatelet medications 61 FOLFOX6 chemotherapy regimen 61 cardio renal 61 Fludarabine 61 ALN TTR 61 Ropinirole 61 RhuDex ® 61 G#DT 61 Oropharyngeal Candidiasis 61 aldosterone antagonist 61 antihypertensive therapy 61 Phase IIIb study 61 MIRAPEX 61 Phase 2a Clinical Trial 61 interferon gamma 1b 61 Carotid Stenting 61 lenalidomide Revlimid R 61 Nocturia 61 arterial thromboembolic events 61 Cell Lymphoma CTCL 61 HIPEC 61 carcinoid syndrome 61 thromboembolic disease 61 CHOP chemotherapy 61 relapsed SCLC 61 multivessel disease 61 constipation predominant IBS 61 hypereosinophilic syndrome 61 somatostatin analogue 61 APTIVUS R 61 landmark ATHENA trial 61 AGHD 61 Myocet 61 bronchogenic carcinoma 61 Demonstrates Sustained 61 Panzem R NCD 61 serum phosphate 61 Immunotherapeutic 61 risperidone Risperdal 61 prospectively stratified 61 orally inhaled migraine 61 Catheter Ablation 61 Xeloda ® 61 dosing cohort 61 somatostatin analogues 61 Xanafide 61 HBeAg negative patients 61 Xyfid TM 61 null responder 61 adjuvant tamoxifen 61 Hyperphosphatemia 61 Myelodysplastic Syndromes 61 ventricular fibrillation VF 61 Combination therapy 61 CRLX# 61 allogeneic HSCT 61 Stage IIB 61 eptifibatide 61 Metastatic Renal Cell Carcinoma 61 colorectal carcinoma 61 Thromboembolic 61 TO AVOID PREGNANCY WHILE 61 Lupus Nephritis 61 beta interferons 61 essential thrombocythemia 61 STENT 61 serotonin norepinephrine reuptake inhibitor 61 Treating Chronic 61 psoriasis Crohn disease 61 ß blockers 61 Adjuvant Chemotherapy 61 antifungal therapy 61 Anticoagulant 61 mcg QD 61 Rheumatoid Arthritis Patients 61 thromboembolic complications 61 stage IIIb 61 xanthine oxidase inhibitor 61 neovascular form 61 Accelerated Partial Breast Irradiation 61 Hyperkalemia 61 nonmetastatic prostate cancer 61 debilitating complication 61 Microplasmin 61 Clinical Trial Evaluating 61 Actinic Keratosis 61 prostate cancer CRPC 61 headache nasopharyngitis 61 Mild Cognitive Impairment 61 Vascugel ® 61 Silodosin 61 neurogenic bladder 61 Newly Diagnosed Multiple Myeloma 61 hypercholesterolemia 61 oral Hycamtin 61 OSAHS 61 Sanvar R 61 benazepril 61 dilated cardiomyopathy DCM 61 malignant ascites 61 carotid artery stenting CAS 61 mediastinitis 61 BEXXAR Therapeutic Regimen 61 YONDELIS 61 Restenosis 60 Paromomycin 60 GI motility disorders 60 lipid lowering agents 60 Combination REOLYSIN R 60 Toxicities 60 RhuDex R 60 ancrod 60 Triapine 60 Daclizumab 60 Long Term Efficacy 60 EURIDIS 60 RhuDex TM 60 refractory anaplastic astrocytoma 60 Dacogen decitabine 60 concurrent chemoradiation 60 Mycophenolate Mofetil 60 mg administered orally 60 Dasatinib 60 bullous 60 Rilonacept 60 variant angina 60 brand ciclesonide HFA 60 Hypercholesterolemia 60 either acutely decompensated 60 pulmonary artery hypertension 60 Bipolar Mania 60 thiazide diuretic 60 paroxetine Paxil 60 Pivotal Clinical Trial 60 Cimzia ® certolizumab pegol 60 candesartan cilexetil 60 capecitabine Xeloda 60 Valdoxan 60 volociximab 60 neovascular age 60 moderate hepatic impairment 60 acyclovir Lauriad R 60 humanised monoclonal antibody 60 BRILINTA 60 Pivotal Phase II 60 acute PAO 60 immune thrombocytopenic purpura 60 KAPIDEX 60 SNT MC# 60 idursulfase 60 Dabigatran 60 LV dysfunction 60 ER CHOP 60 Eisenmenger syndrome 60 IPL# 60 DEFLUX 60 methotrexate therapy 60 GnRH agonists 60 Left Ventricular Dysfunction 60 Bucindolol 60 double blinded placebo 60 SSRI citalopram 60 romiplostim 60 posterior uveitis 60 hemodynamically significant 60 constipation predominant irritable bowel 60 riociguat 60 carotid endarterectomy CEA 60 Percutaneous Coronary Intervention 60 recurrent NSCLC 60 dysmenorrhea 60 Patients Treated 60 ZACTIMA 60 Zolpimist ™ 60 Clolar ® 60 melphalan prednisone 60 Sanofi Aventis Taxotere 60 antibiotic prophylaxis 60 Dyloject TM 60 VaD 60 resynchronization therapy 60 evaluating tivozanib 60 conventional DMARDs 60 Torisel 60 Panzem R 60 Patients Undergoing 60 Obstructive Sleep Apnea 60 Phase 2b Trial 60 Heart Failure Patients 60 cutaneous melanoma 60 mechanical thrombectomy 60 denileukin diftitox 60 systemic lupus erythematosus 60 systemic hypotension 60 idiopathic scoliosis 60 cytopenias 60 Cimzia certolizumab pegol 60 cetuximab Erbitux R 60 Diabetic Neuropathy 60 vitreous hemorrhage 60 opioid induced bowel dysfunction 60 irbesartan 60 hepatic insufficiency 60 tumor lysis syndrome 60 Acute Myocardial Infarction AMI 60 ACE Inhibitor 60 Interferon Alfa 60 ibandronate 60 Central Retinal Vein 60 gastric carcinoma 60 rituximab refractory 60 dopaminergic therapy 60 Minimally Invasive Procedure 60 Growth Hormone Deficiency 60 severe exacerbations 60 liver resection 60 Levetiracetam 60 Acute Renal Failure 60 Thrombocytopenia 60 Hedgehog Pathway Inhibitor 60 Patient Outcomes 60 HCV Genotype 60 Fludara 60 Arteriovenous 60 recurrent glioma 60 Personalized Immunotherapy 60 Aryplase 60 Metastatic Melanoma 60 acute mania 60 RLAI 60 Shows Efficacy 60 ceftazidime 60 Invasive Breast Cancer 60 Candesartan 60 nonalcoholic steatohepatitis NASH 60 lexidronam injection 60 oral anticoagulant 60 DU #b 60 including eniluracil ADH 60 rt PA 60 SJIA 60 vinorelbine 60 Dementia Related Psychosis 60 Leukemias 60 CTAP# Capsules 60 2 methoxyestradiol 60 Pegloticase 60 Investigational Agent 60 symptomatic paroxysmal AF 60 desvenlafaxine succinate 60 aldosterone antagonists 60 Novel Inhibitor 60 Dyslipidemia 60 cystoid macular edema 60 GnRH agonist 60 thromboembolic 60 perioperatively 60 cisplatin vinorelbine 60 antiplatelet agent 60 Chronic Constipation 60 haematological cancers 60 Eculizumab 60 AFREZZA TM 60 Degenerative Disc Disease 60 polymyalgia rheumatica 60 Acute Exacerbations 60 genitourinary GU 60 Pivotal Phase 60 ORAL HYCAMTIN 60 acne vulgaris 60 pregabalin Lyrica 60 Melphalan 60 Ecallantide 60 geographic atrophy 60 RoACTEMRA 60 hyperlipidaemia 60 ENGAGE AF TIMI 60 Infusion Reactions Severe 60 prokinetic agent 60 Chronic Hepatitis C 60 nadroparin 60 prostate cancer CaP 60 Atherosclerotic 60 FIRMAGON 60 treat chronic sinusitis 60 lichen planus 60 daily subcutaneous injections 60 diabetic retinopathy DR 60 Combination Treatment 60 vitreous floaters 60 FUSILEV enhances 60 CIMZIA R 60 personalized cellular immunotherapy 60 OZURDEX ® 60 macular edema secondary 60 CINTREDEKIN BESUDOTOX 60 Pulmonary Arterial Hypertension PAH 60 histologically proven 60 thromboembolic events 60 metastatic malignant melanoma 60 TEMODAL 60 PRoFESS 60 ICD implantation 60 inhaled bronchodilators 60 HIV HCV coinfected 60 Initiates Phase 2b 60 CALGB 60 refractory metastatic 60 Phase IIb clinical trials 60 Lung transplantation 60 Anthracycline 60 imipenem 60 ADAGIO study 60 Carotid Revascularization Endarterectomy vs. 60 selective modulator 60 Acute Heart Failure 60 1mg 2mg 60 Teriparatide 60 Cloretazine 60 TBC# 60 intracerebral haemorrhage 60 Advanced Prostate Cancer 60 Protease Inhibitors 60 peripheral artery 60 Tumor Response 60 PANVAC VF 60 Zenvia ™ 60 stable angina 60 Decitabine 60 pioglitazone HCl 60 relapsed AML 60 Nonalcoholic Steatohepatitis 60 Denufosol 60 ULORIC 60 docetaxel cisplatin 60 juvenile idiopathic arthritis JIA 60 OZURDEX 60 Bone Metastases 60 Demonstrates Positive 60 elective PCI 60 Asacol R 60 velafermin 60 Chronic lymphocytic leukemia 60 non squamous NSCLC 60 Bevacizumab 60 portal vein thrombosis 60 Quetiapine 60 radical nephrectomy